Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Variability in the Use of Simulation for Procedural Training in Radiology Residency: Opportunities for Improvement.

Matalon SA, Chikarmane SA, Yeh ED, Smith SE, Mayo-Smith WW, Giess CS.

Curr Probl Diagn Radiol. 2018 Mar 19. pii: S0363-0188(18)30005-7. doi: 10.1067/j.cpradiol.2018.02.008. [Epub ahead of print]

PMID:
29656883
2.

The Impact of Residual Disease After Preoperative Systemic Therapy on Clinical Outcomes in Patients with Inflammatory Breast Cancer.

Nakhlis F, Regan MM, Warren LE, Bellon JR, Hirshfield-Bartek J, Duggan MM, Dominici LS, Golshan M, Jacene HA, Yeh ED, Mullaney EE, Overmoyer B.

Ann Surg Oncol. 2017 Sep;24(9):2563-2569. doi: 10.1245/s10434-017-5903-6. Epub 2017 May 30.

PMID:
28560598
3.

Avoiding Pitfalls, Maximizing Success at Image-guided Breast Interventions: A Pictorial Review.

Yeh ED, Frost EP, Raza S, Birdwell RL, Giess CS.

Curr Probl Diagn Radiol. 2017 Mar - Apr;46(2):161-169. doi: 10.1067/j.cpradiol.2016.02.008. Epub 2016 Feb 20. Review.

PMID:
27017404
4.

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.

Tolaney SM, Boucher Y, Duda DG, Martin JD, Seano G, Ancukiewicz M, Barry WT, Goel S, Lahdenrata J, Isakoff SJ, Yeh ED, Jain SR, Golshan M, Brock J, Snuderl M, Winer EP, Krop IE, Jain RK.

Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14325-30. doi: 10.1073/pnas.1518808112. Epub 2015 Nov 2.

5.

Inflammatory breast cancer and development of brain metastases: risk factors and outcomes.

Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR.

Breast Cancer Res Treat. 2015 May;151(1):225-32. doi: 10.1007/s10549-015-3381-8. Epub 2015 Apr 17.

PMID:
25893587
6.

Inflammatory Breast Cancer: Patterns of Failure and the Case for Aggressive Locoregional Management.

Warren LE, Guo H, Regan MM, Nakhlis F, Yeh ED, Jacene HA, Hirshfield-Bartek J, Overmoyer BA, Bellon JR.

Ann Surg Oncol. 2015 Aug;22(8):2483-91. doi: 10.1245/s10434-015-4469-4. Epub 2015 Mar 20.

PMID:
25791789
7.

Patient compliance and diagnostic yield of 18-month unilateral follow-up in surveillance of probably benign mammographic lesions.

Chung CS, Giess CS, Gombos EC, Frost EP, Yeh ED, Raza S, Birdwell RL.

AJR Am J Roentgenol. 2014 Apr;202(4):922-7. doi: 10.2214/AJR.13.11137.

PMID:
24660725
8.

Positioning in breast MR imaging to optimize image quality.

Yeh ED, Georgian-Smith D, Raza S, Bussolari L, Pawlisz-Hoff J, Birdwell RL.

Radiographics. 2014 Jan-Feb;34(1):E1-17. doi: 10.1148/rg.341125193.

PMID:
24428300
9.

Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation.

Giess CS, Yeh ED, Raza S, Birdwell RL.

Radiographics. 2014 Jan-Feb;34(1):234-47. doi: 10.1148/rg.341135034.

PMID:
24428293
10.

What radiologists need to know about diagnosis and treatment of inflammatory breast cancer: a multidisciplinary approach.

Yeh ED, Jacene HA, Bellon JR, Nakhlis F, Birdwell RL, Georgian-Smith D, Giess CS, Hirshfield-Bartek J, Overmoyer B, Van den Abbeele AD.

Radiographics. 2013 Nov-Dec;33(7):2003-17. doi: 10.1148/rg.337135503.

PMID:
24224593
11.

Breast magnetic resonance imaging: current clinical indications.

Yeh ED.

Obstet Gynecol Clin North Am. 2011 Mar;38(1):159-77, ix. doi: 10.1016/j.ogc.2011.02.008. Review.

PMID:
21419332
12.

Breast magnetic resonance imaging: current clinical indications.

Yeh ED.

Magn Reson Imaging Clin N Am. 2010 May;18(2):155-69, vii. doi: 10.1016/j.mric.2010.02.009. Review.

PMID:
20494303
13.

Analysis of the mammographic and sonographic features of pseudoangiomatous stromal hyperplasia.

Hargaden GC, Yeh ED, Georgian-Smith D, Moore RH, Rafferty EA, Halpern EF, McKee GT.

AJR Am J Roentgenol. 2008 Aug;191(2):359-63. doi: 10.2214/AJR.07.2479.

PMID:
18647902
14.

Detecting nonpalpable recurrent breast cancer: the role of routine mammographic screening of transverse rectus abdominis myocutaneous flap reconstructions.

Lee JM, Georgian-Smith D, Gazelle GS, Halpern EF, Rafferty EA, Moore RH, Yeh ED, D'Alessandro HA, Hitt RA, Kopans DB.

Radiology. 2008 Aug;248(2):398-405. doi: 10.1148/radiol.2482071635. Epub 2008 Jun 6.

PMID:
18539887
15.

Blinded comparison of computer-aided detection with human second reading in screening mammography.

Georgian-Smith D, Moore RH, Halpern E, Yeh ED, Rafferty EA, D'Alessandro HA, Staffa M, Hall DA, McCarthy KA, Kopans DB.

AJR Am J Roentgenol. 2007 Nov;189(5):1135-41.

PMID:
17954651
17.

Hormone replacement therapy in postmenopausal women: breast tissue perfusion determined with MR imaging--initial observations.

Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Halpern EF, Garrido L.

Radiology. 2005 Apr;235(1):36-41.

PMID:
15798166
18.

Effect of tamoxifen on breast tissue density in premenopausal breast cancer.

Slanetz PJ, Grandpre LE, Yeh ED, Kopans DB, Mendel JB.

Breast J. 2004 Jan-Feb;10(1):27-32.

PMID:
14717756
19.

Characterization of breast lesions with proton MR spectroscopy.

Yeh ED.

AJR Am J Roentgenol. 2003 Nov;181(5):1273-4. No abstract available.

PMID:
14573419
20.

Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study.

Delille JP, Slanetz PJ, Yeh ED, Halpern EF, Kopans DB, Garrido L.

Radiology. 2003 Jul;228(1):63-9. Epub 2003 May 29.

PMID:
12775851

Supplemental Content

Loading ...
Support Center